Synthesis and Characterization of Poloxamer 188-grafted Heparin Copolymer
Overview
Authors
Affiliations
Background: Poloxamer 188 is a safe biocompatible polymer that can be used in protein drug delivery system.
Aim: In this study, a new heparin-poloxamer 188 conjugate (HP) was synthesized and its physicochemical properties were investigated. HP structure was confirmed by Fourier transform infrared spectroscopy (FTIR) and Hydrogen-1 nuclear magnetic resonance spectroscopy ((1)H-NMR). Content of the conjugated heparin was analyzed using Toluidine Blue. The critical micelle concentration (CMC) of the copolymer was determined by a fluorescence probe technique. The effect of HP on the gelation of poloxamer 188 was characterized by the rheological properties of the HP-poloxamer hydrogels. Solubility and viscosity of HP were also evaluated compared with poloxamer 188.
Results: From the results, the solubility of the conjugated heparin was increased compared with free heparin. The content of heparin in HP copolymer was 62.9%. The CMC of HP and poloxamer 188 were 0.483 and 0.743 mg/mL, respectively. The gelation temperature of 0.4 g/mL HP was 43.5 degrees C, whereas that of the same concentration of poloxamer 188 was 37.3 degrees C. With HP content in poloxamer 188 solution increasing, a V-shape change of gelation temperature was observed.
Conclusion: Considering the importance of poloxamer 188 in functional material, HP may prove to be a facile temperature-sensitive material for protein drug-targeted therapy.
Synthesis of F127-GA@ZnO nanogel as a cisplatin drug delivery pH-sensitive system.
Son N, Thanh V, Huong N RSC Adv. 2024; 14(47):35005-35020.
PMID: 39497764 PMC: 11533520. DOI: 10.1039/d4ra06514j.
Uddin A, Halder S, Deb N, Das H, Shuma M, Hasan I Adv Pharmacol Pharm Sci. 2024; 2024:2303942.
PMID: 38835733 PMC: 11150040. DOI: 10.1155/2024/2303942.
Main Aspects of Pharmaceutical Development of Immunobiological Drugs for Intranasal Administration.
Bakhrushina E, Mikhel I, Kondratieva V, Demina N, Grebennikova T, Krasnyuk Jr I Curr Pharm Biotechnol. 2023; 25(11):1394-1405.
PMID: 37842893 DOI: 10.2174/0113892010260017231002075152.
Biomedical applications of engineered heparin-based materials.
Zare E, Khorsandi D, Zarepour A, Yilmaz H, Agarwal T, Hooshmand S Bioact Mater. 2023; 31:87-118.
PMID: 37609108 PMC: 10440395. DOI: 10.1016/j.bioactmat.2023.08.002.
Ghamkhari A, Tafti H, Rabbani S, Ghorbani M, Ghiass M, Akbarzadeh F ACS Omega. 2023; 8(12):11335-11350.
PMID: 37008126 PMC: 10061684. DOI: 10.1021/acsomega.3c00067.